RWIBX
Price
$70.45
Change
+$0.45 (+0.64%)
Updated
Jul 3 closing price
Net Assets
135.98B
VEIGX
Price
$38.61
Change
+$0.07 (+0.18%)
Updated
Jul 3 closing price
Net Assets
1.43B
Interact to see
Advertisement

RWIBX vs VEIGX

Header iconRWIBX vs VEIGX Comparison
Open Charts RWIBX vs VEIGXBanner chart's image
American Funds Capital World Gr&Inc R2
Price$70.45
Change+$0.45 (+0.64%)
VolumeN/A
Net Assets135.98B
Vanguard Global ESG Select Stk Investor
Price$38.61
Change+$0.07 (+0.18%)
VolumeN/A
Net Assets1.43B
RWIBX vs VEIGX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RWIBX vs. VEIGX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RWIBX is a Buy and VEIGX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 136B vs. VEIGX (1.43B). VEIGX pays higher dividends than RWIBX: VEIGX (1.49) vs RWIBX (0.82). RWIBX was incepted earlier than VEIGX: RWIBX (23 years) vs VEIGX (6 years). RWIBX (1.51) is less costly to investors than VEIGX (0.58). VEIGX is a more actively managed with annual turnover of: 33.00 vs. RWIBX (27.00). RWIBX has a lower initial minimum investment than VEIGX: RWIBX (250) vs VEIGX (3000). RWIBX (8.46) and VEIGX (8.30) have marching annual gain over last year. VEIGX return over 5 years is better than : 77.89 vs. RWIBX (48.76).
RWIBXVEIGXRWIBX / VEIGX
Total Expense Ratio1.510.58260%
Annual Report Gross Expense Ratio1.510.58260%
Fund Existence23 years6 years-
Gain YTD13.1447.161184%
Front LoadN/AN/A-
Min. Initial Investment25030008%
Min. Initial Investment IRAN/AN/A-
Net Assets136B1.43B9,484%
Annual Yield % from dividends0.821.4955%
Returns for 1 year8.468.30102%
Returns for 3 years47.2644.95105%
Returns for 5 years48.7677.8963%
Returns for 10 years58.14N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OMGAQ0.040.01
+26.21%
Omega Therapeutics, Inc.
IBJHF2.06N/A
N/A
Ibstock PLC
NBVAF0.08N/A
N/A
Nubeva Technologies Ltd.
HLBBF6.00N/A
N/A
H. Lundbeck A/S
CAOVY8.66-0.26
-2.91%
China Overseas Land & Investment Ltd.